药捷安康(南京)科技股份有限公司（药捷安康-B，股份代号：02617）于2026年10月23日公告披露，公司于当日通过香港联交所场内回购股份52,500股，约占现有已发行股份（不包括库存股份）的0.02%。
本次回购价格区间为每股8.55港元至8.79港元，合计耗资约45.87万港元。回购完成后，公司已发行股份总数仍为313,347,673股，其中不包括库存股份的已发行股份数为312,571,673股，库存股份数增至776,000股。
公司此前于2026年6月18日通过了回购授权，授权回购股份数量为31,268,767股。截至公告日，公司已根据该项授权累计回购股份776,000股，占授权当日已发行股份总数（不包括库存股份）的0.25%。公司表示，本次回购已获得董事会正式授权，并遵守了香港联交所相关上市规则及适用的法律法规。
本公告由公司董事长兼首席执行官吴永谦签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.